Cage Pharma – Targeting Cancer Metabolism Founder of Cage Pharma, Jeff Geschwind, MD, researches glycolysis inhibitors to disrupt tumor growth. His work opens new avenues for metabolism-based cancer drugs, promising more effective treatments. https://www.usaveinclinics.com/vein-specialist/jean-francois-geschwind/